DTx Algorithms for Personalized Parkinson's Disease Treatment and Medication Plan Optimization
Development of Digital Therapeutics Algorithms for Personalized Parkinson's Disease Treatment and Medication Plan Optimization
Sponsor: Mediolanum Cardio Research
This observational or N/A phase trial investigates Parkinson Disease and is currently completed. Mediolanum Cardio Research leads this study, which shows 8 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Nov 2024 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2024 — Jun 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2023 — Jan 2024 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting
Status: Not Yet Recruiting → Active Not Recruiting
-
Jul 2023 — Nov 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mediolanum Cardio Research
- Michael J. Fox Foundation for Parkinson's Research
- Newel Health SRL
For direct contact, visit the study record on ClinicalTrials.gov .